e treated 106 patients with a peripheral osteoid osteoma by conventional surgical methods; 81 had curettage and 25 en-bloc resection.
Osteoid osteoma, originally described by Jaffe in 1935, is a benign osteoblastic tumour of unknown aetiology. 1 It is usually less than 2 cm in diameter with distinct margins surrounded by a sclerotic zone of reactive new bone. [1] [2] [3] [4] [5] [6] Osteoid osteoma represents about 10% to 12% of benign bone tumours. 1, [4] [5] [6] Patients are usually younger than 25 years with a male:female ratio which varies between 2:1 and 5:1. The lesion usually occurs in the limbs with more than 50% of cases in the femur or tibia. 1, 4, 5 The clinical diagnosis is based on the typical intrinsic pain at night and at rest which is responsive to medical treatment with analgesics, particularly aminosalicylic acid, and on CT and scintigraphic findings such as the 'doubledensity sign'. 1, 2, 5, 6 Since radiological changes may occur late, the time between the onset of symptoms and the definitive diagnosis is often more than a year. 1, 6 Treatment is aimed at the removal of the nidus, either in the traditional manner by en-bloc resection, by curettage, or by a variety of other methods. 1, 2, 4, [6] [7] [8] [9] We present a retrospective study which evaluates the incidence of recurrence and complications in patients treated by conventional surgical methods, and compares them with those observed after treatment by contemporary methods reported in the literature.
Patients and Methods
Between August 1958 and December 1996, we treated 125 patients (126 tumours) surgically for osteoid osteoma. In 106 cases the tumour was located in a limb, most commonly in the femur (45) followed by the tibia (33), hand (12) and foot (6) . Other sites accounted for less than 10% (radius, 4; humerus, 2; fibula, 2 and ulna, 2). One patient underwent surgery for osteoid osteoma in the radius in both arms. Axial locations included the spine (15), clavicle (1), ileum (2), ischium (1) and skull (1) . The tumours were located in 79 men and 27 women who had a mean age at the time of treatment of 20 years (3 to 49). Before operation, 102 patients suffered from pain with a mean duration of 16 months (1 to 72); 88 had the characteristic pain at night. Only two patients complained of local swelling and one had no symptoms. Curettage was performed in 81 tumours and en-bloc resection in 25.
The mean follow-up was for 13 years (2 to 37). Of the 105 patients, 88 (83%) were reviewed. Those with a follow-up of less than 15 years (57) were evaluated clinically; the others were interviewed by telephone with respect to complications with inflammation or infection in the surgical wound and function of the respective limb, including weight-bearing.
Of those lost to follow-up, four patients had died from unrelated causes. Seventeen could not be traced, of whom seven absented themselves shortly after surgery.
Results
Curettage. Of the surgical procedures 37 (45.7%) were carried out on the femur, 20 (24.7%) on the tibia, 12 (14.8%) on the hand and six (7.4%) on the foot. In addition, three were on the radius, two on the humerus and one on the fibula. Two patients underwent laser treatment, one on the humerus and one on the foot. In seven patients plates were implanted for structural support; four in the femur and three in the tibia. Three patients so treated complained of localised pain which disappeared after their removal of the plate. Five patients reported sensitivity to the weather, six suffer from pain when carrying a heavy load and one has persistent local tenderness. In all patients this pain is different from that experienced before surgery. No complications were seen in 43 of 66 patients (65%) who were followed up while 13 (20%) had minor complications. The tumour recurred in eight patients (12%); four in the femur, two in the tibia, and one each in a finger and toe. Recurrence was seen within six months of surgery in five patients, after a year in two and after two years in one. Further surgery was necessary in all eight. A fracture within the area treated by surgery occurred twice, both in the tibia, one at four weeks after simple curettage and the other two weeks after removal of a plate which had been inserted during revision surgery. En-bloc resection. In these cases a somewhat different distribution was observed. Of the 25 operations, 13 (52%) involved the tibia, eight (32%) the femur, two the ulna, and one each the radius and the fibula. In 14 patients (56%) a plate was implanted; in the femur in five, the tibia in eight and in the fibula in one. No postoperative complications were seen in 12 of 22 patients (54.5%) who were followed up, and only seven patients (32%) had minor complications.
Pain over the implant was observed in six patients. Four reported pain when carrying a heavy load and another complained of local tenderness. In all patients the pain was much less severe than that experienced before operation. One patient underwent drainage for infection and one developed a local recurrence in the femur, eight years after surgery. This has been diagnosed recently and the patient awaits revision surgery. One patient with a plate spanning an en-bloc resection had a fracture two months later.
Either no or only minor complications were reported by 56 patients (85%) after curettage and by 19 (86.5%) after en-bloc resection.
Discussion
Our results show that after curettage 85% of patients were free from complications compared with 86.5% after en-bloc resection. Fracture occurred in two patients after curettage, and in one after en-bloc resection. Kirschner wire, which was introduced into the nidus, followed by a the use of a 6 to 8 mm Meunier bone biopsy trephine and finally a high-speed burr. The authors describe one failure (1 of 7; 14.3%) at a minimum follow-up of two years. There was no difference in the incidence of local recurrence after traditional surgery in our study compared with that reported in the literature after minimally invasive surgery. The number of patients in our study, however, is 10 We noted three local recurrences which presented more than 18 months after surgery. The advantages of minimally invasive therapy are the modest wound, short hospitalisation and cost-effectiveness. Furthermore, no case of fracture has been mentioned in the literature. The disadvantage, as stated by Gangi et al, 9 is that only typical osteoid osteomas can be treated in this way. Furthermore, it is indicated only for small tumours located at least 1 cm from major nerves. 9 Rosenthal et al 7 compared operative excision with percutaneous radiofrequent coagulation. The incidence of recurrence after operative treatment was 9% (6 of 68) compared with 12% (4 of 33). Both groups suffered only minor complications. Ward et al 11 reported 15 patients who were treated either using a high-speed burr or by removing the nidus with a curette. There were no local recurrences after either technique. They concluded that, from an oncological point of view, removal of the nidus is the essential feature. Minimally invasive techniques are now generally accepted as being the procedure of choice in deeply situated or inaccessible tumours, after precise preoperative localisation. When the tumour is readily accessible in the tibia, hand or foot, or when there remains doubt regarding the diagnosis, curettage through a small skin incision takes no longer and is no more invasive than other techniques. For these reasons curettage as a traditional surgical procedure is still justified. En-bloc resection, because of the high incidence of associated complications, should be reserved for recurrent lesions.
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